How can pharma provide access to medicine in the world's rising econom…

24/05/2013

Tara Prasad

As our market access focus continues, Tara Prasad highlights the importance of global initiatives to help patients in the least developing countries gain access to medicine and discusses the role...

Pharma news highlights: court cases, controversy and transparency

23/05/2013

Ed Silverman

Ed Silverman shares his thoughts on some of the latest pharma news stories from the last four weeks, including court cases in South Korea and the US, as well as...

Thailand pharmaceutical market update, 2013

23/05/2013

Ames Gross

Ames Gross of Pacific Bridge Medical provides an overview of the pharmaceutical market in Thailand. Thailand's pharmaceutical market was worth $4.4 billion in 2012, making it larger than any other market...

Promoting transparency to avoid costly healthcare mistakes – the CHEER…

22/05/2013

Donald Husereau

Donald Husereau highlights the benefits of the recent CHEERS guidelines to biomedical publishing. More than ever, rising healthcare costs have led to the need for good healthcare decisions. Yet the information...

Boehringer, Lilly launch type 2 diabetes game

24/05/2013

Hannah Blake

Boehringer Ingelheim and Eli Lilly & Company have launched an educational digital game for type 2 diabetes patients called Complications Combat. The game is designed to raise awareness of the many...

J&J plans to submit 10 new drugs for approval by 2017

23/05/2013

Hannah Blake

Johnson & Johnson's pharmaceuticals segment plans to submit 10 new product filings for regulatory approval over the next four years. These products are aimed at addressing serious unmet medical needs,...

FDA panel recommends Merck’s insomnia drug for approval

23/05/2013

Hannah Blake

An FDA advisory panel has voted in favour of Merck & Co's experimental insomnia drug, saying that it is safe and effective for elderly patients at the lower of two...

Novo acquires Xellia Pharma for $700m

22/05/2013

Hannah Blake

Novo A/S has announced its acquisition of Xellia Pharmaceuticals for US $700 million. Novo A/S is the holding company of the Novo Group, which is the major shareholder in Danish pharma...

Open access in medical journals - interv…

Executive perspectives: Bruno Strigini

Doctors hold the key to understanding pa…

Carly Brown

Pharma is recognising the increasing importance of the patient voice in providing feedback on how medicines are utilised in a real-world setting and the impact they are having on outcomes....

Outcomes shape the new payer networks fo…

Marcelo Fantoni

The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which...

Publishing white papers on pharmaphorum

Paul Tunnah

As a new feature on pharmaphorum, we unveil pharmaceutical industry white papers as part of our media section. Download this one page document to understand how to publish your deep...